Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Share-based Compensation (2016 - 2023)

Historic Share-based Compensation for Cellectis (CLLS) over the last 9 years, with Q4 2023 value amounting to $4.6 million.

  • Cellectis' Share-based Compensation rose 109405.68% to $4.6 million in Q4 2023 from the same period last year, while for Dec 2023 it was $5.2 million, marking a year-over-year decrease of 1340.39%. This contributed to the annual value of $3.2 million for FY2024, which is 3948.02% down from last year.
  • As of Q4 2023, Cellectis' Share-based Compensation stood at $4.6 million, which was up 109405.68% from -$2.7 million recorded in Q3 2023.
  • In the past 5 years, Cellectis' Share-based Compensation ranged from a high of $8.0 million in Q3 2019 and a low of -$2.8 million during Q4 2020
  • For the 5-year period, Cellectis' Share-based Compensation averaged around $3.0 million, with its median value being $2.8 million (2020).
  • Its Share-based Compensation has fluctuated over the past 5 years, first soared by 762000.0% in 2022, then crashed by 29962.38% in 2023.
  • Cellectis' Share-based Compensation (Quarter) stood at $7.1 million in 2019, then plummeted by 139.19% to -$2.8 million in 2020, then skyrocketed by 169.53% to $1.9 million in 2021, then tumbled by 79.98% to $387000.0 in 2022, then skyrocketed by 1094.06% to $4.6 million in 2023.
  • Its Share-based Compensation stands at $4.6 million for Q4 2023, versus -$2.7 million for Q3 2023 and $1.6 million for Q2 2023.